NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
Learn more about NuvaRing®: call 1-877-NUVARING (1-877-688-2746)
 
Send this page to a friend
 
 
 

How Do I Use It?

NuvaRing® is a small, comfortable vaginal ring that’s easy to insert and remove. The exact position of NuvaRing® is not important for it to be effective. Once inserted, NuvaRing® molds to your body and should stay in place—even during exercise.

How to insert NuvaRing®

After washing and drying your hands, remove NuvaRing® from the foil pouch. Holding NuvaRing® between your thumb and index finger, press the sides together while lying down, squatting, or standing with one leg up—whatever is most comfortable for you.

Gently push the folded ring into your vagina. If you feel discomfort after inserting NuvaRing®, slide it farther in until it feels comfortable. The exact position of NuvaRing® is not important for it to be effective. Once inserted, keep NuvaRing® in place for 3 weeks in a row.

How to remove NuvaRing®

Remove the ring 3 weeks after insertion on the same day of the week it was inserted at about the same time. Hook your index finger under the forward rim or hold the rim between your index and middle finger.

Gently pull out NuvaRing®. Dispose of NuvaRing® in a waste receptacle out of the reach of children and pets. Do not throw it in the toilet. To continue to have pregnancy protection, you must insert a new ring 1 week after the last one was removed even if your period has not stopped.

Next: Possible Side Effects and Risks >>
 
 
 
 
 

Prescription NuvaRing® is a flexible vaginal ring approved for the prevention of pregnancy in women.

For additional important information, please see the FULL PRODUCT INFORMATION, INCLUDING BOXED WARNING.

IMPORTANT SAFETY INFORMATION:

  • The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, which may lead to stroke or heart attack. NuvaRing® is not for women with a history of these conditions. The risk of getting blood clots may be greater with the type of progestin in NuvaRing® than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing® use than with the use of certain birth control pills
  • Cigarette smoking increases the risk of serious cardiovascular side effects, especially in women over 35; women who use combination hormonal contraceptives, including NuvaRing®, are strongly advised not to smoke
  • NuvaRing® is not for women with certain cancers or those who may be pregnant. NuvaRing® does not protect against HIV infection and other sexually transmitted diseases
  • The most common side effects reported by NuvaRing® users are: vaginal infections and irritation, vaginal secretion, headache, weight gain, and nausea

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


Home | Privacy | Terms of Use | Full Prescribing Information | Site Map | Contact Us

Learn more about NuvaRing®: 1-877-NUVARING

This site is intended for U.S. residents.